Company Filing History:

20 out of 854

Roussel Uclaf

patents

Hoechst Marion Roussel

patents

Years Active: 1989-2007

Loading Chart...

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE39743 - 2-halogenated derivatives of 5-0 desosaminyl-erythronolide a, their preparation process and their antibiotic use (2007-07-23),

2. 7119180 - 2-halogenated derivatives of 5-O-desosaminyl-erythronolide A, their preparation process and their antibiotic use (2006-10-10),

3. RE38520 - Erythromycin derivatives, method for preparing same, and use thereof as drugs (2004-05-18),

4. 6455505 - Derivatives . . . use as medicaments (2002-09-24),

5. 6407257 - Derivatives of erythromycin, their preparation process and their use as medicaments (2002-06-18),

6. 6352983 - 2-halogenated derivatives of 5-0 desosaminyl-erythronolide A, their preparation process and their antibiotic use (2002-03-05),

7. 6162793 - Erythromycin derivatives, method for preparing same and use thereof as (2000-12-19),

8. 6100404 - Erythromycin compounds (2000-08-08),

9. 6096714 - Erythromycin derivatives, method for preparing same, and use thereof as (2000-08-01),

10. 5786339 - Erythromycins (1998-07-28),

11. 5770579 - Erythromycin compounds (1998-06-23),

12. 5760233 - Propanal derivatives (1998-06-02),

13. 5747467 - Erythromycins (1998-05-05),

14. 5656607 - Erythromycin derivatives (1997-08-12),

15. 5635485 - Erythromycin compounds (1997-06-03),

Title: The Innovations of Constantin Agouridas

Introduction: Constantin Agouridas is a notable inventor based in Nogent sur Marne, France. With a remarkable portfolio of 29 patents, he has made significant contributions to the field of pharmaceuticals and antibiotic research. His innovative work has impacted the development of novel compounds that exhibit essential properties in the medical field.

Latest Patents: Among his latest patents are two groundbreaking inventions: the 2-halogenated derivatives of 5-O-desosaminyl-erythronolide A, alongside their preparation processes and antibiotic uses. These compounds have been defined through specific formulas in his applications, indicating their potential applications as antibiotics. The invention focuses on the preparation process of these compounds, showcasing their capability to act as effective antibiotics.

Career Highlights: Constantin Agouridas has built a successful career by collaborating with prominent companies in the pharmaceutical industry. His professional journey includes significant tenure at Roussel Uclaf and Aventis Pharma, where he contributed rich insights and innovative ideas to research and development projects.

Collaborations: Throughout his career, Agouridas has collaborated with distinguished colleagues such as Alexis Denis and Jean-Francois Chantot. These partnerships have played a vital role in enhancing his research and expanding the impact of his inventions in the pharmaceutical domain.

Conclusion: With a strong foundation in patent innovation, Constantin Agouridas exemplifies the spirit of creativity and scientific inquiry. His work has not only advanced antibiotic research but also enriched the pharmaceutical industry, ensuring that his contributions will be recognized and valued for years to come.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.